top of page
health
  • Health Insight Test

    Our advanced research algorithms analyse 700,000 data points to provide you with in-depth insights into your health.

    As we all know, people with various ethnic backgrounds, such as South Asian versus European, have varying risk assessments for specific diseases such as diabetes and heart disease.

    We are one of the only companies in the UK to perform this examination of your

    ancestry before applying our advanced algorithm.

     

    • Complex Diseases: GWAS In this part of our report, we leverage GWAS publications, a research method comparing DNA markers in individuals with and without certain diseases. While not diagnostic, these studies offer valuable insights for early detection and prevention, highlighting potential genetic factors to monitor. It's important to recognize that complex diseases are influenced by multiple factors beyond genetics, including lifestyle and diet, which often have significant impacts.

     

    • Cancer Mutations: Mutations Here, we delve into mutations within key genes from an oncological perspective. Our focus is on identifying mutations known as pathogenic in major scientific communities, shedding light on potential cancer risks.

     

    • Biomarkers, Biometrics, and Traits This section employs GWAS statistical analyses to assess your genetic predisposition to specific metabolic parameter abnormalities. By examining biomarkers and biometrics, we provide insights into potential health risks and personalized intervention opportunities.

     

    • Hereditary Diseases We explore genetic mutations associated with hereditary conditions that can be passed down to future generations. Even if carriers remain symptom-free, there's a risk of transmitting these conditions to offspring. Genetic testing for both prospective parents before conception is essential to mitigate these risks. If hereditary diseases are prevalent in your family, genetic testing offers vital guidance from geneticists on preventive measures and family planning strategies.

     

    Here is a list of conditions we test for. Please note the list may vary at time of testing due to various factors not limited to advances in technology or even further scientific data of relevance, etc.

     

    Cancers:

    • Breast cancer
    • Prostate cancer 
    • Bladder cancer
    • Upper aerodigestive tract cancers 
    • Basal cell carcinoma 
    • Squamous cell carcinoma
    • Non-melanoma skin cancer
    • Glioma 
    • Hodgkin’s lymphoma 
    • Diffuse large B-cell lymphoma 
    • Follicular lymphoma 
    • Testicular germ cell tumor 
    • Wilms tumor 

    Endocrine Disorders:

    • Hypothyroidism
    • Type 1 diabetes 
    • Type 2 diabetes 

    Neurological Disorders:

    • Alzheimer’s disease (late onset)
    • Parkinson’s disease
    • Multiple sclerosis
    • Schizophrenia 
    • Myasthenia gravis
    • Neuroblastoma 

    Respiratory Disorders:

    • Chronic bronchitis and chronic obstructive pulmonary disease 
    • Asthma (childhood onset) 

    Autoimmune Disorders:

    • Rheumatoid arthritis
    • Celiac disease 
    • Psoriasis 

    Cardiovascular Disorders:

    • Intracranial aneurysm 
    • Coronary heart disease
    • Myocardial infarction (early onset)

    Musculoskeletal Disorders:

    • Osteosarcoma

    Gynaecology:

    • Endometriosis

    Genetic Disorders: ( We are not able to distinguish between carrier types within the test limits. )

    • Microcephaly 3, Primary, Autosomal Recessive
    • Microcephaly 5, Primary, Autosomal Recessive
    • Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 1
    • Osteogenesis Imperfecta, Type Ii
    • Noonan Syndrome 1
    • Noonan Syndrome-Like Disorder With Or Without Juvenile Myelomonocytic Leukemia
    • Myopathy, Myofibrillar, 1
    • Myopathy Centronuclear
    • Myopathy, Centronuclear, X-Linked
    • Long Qt Syndrome 1
    • Leigh Syndrome
    • Leopard Syndrome 1
    • Leukoencephalopathy With Vanishing White Matter
    • Lissencephaly 1
    • Polymicrogyria, Bilateral Frontoparietal
    • Niemann-Pick Disease, Type A
    • Cystinosis, Nephropathic
    • Nemaline Myopathy 2
    • Loeys-Dietz Syndrome 2
    • Maple Syrup Urine Disease
    • Meckel Syndrome, Type 3
    • Pontine And Cerebellar Hypoplasia
    • Metachromatic Leukodystrophy
    • Methylmalonic Aciduria And Homocystinuria, Cblc Type
    • Niemann-Pick Disease, Type B
    • Melanocortin 4 Receptor Deficiency
    • Albinism, Oculocutaneous, Type Ib
    • Osteogenesis Imperfecta, Type Iii
    • Retinitis Pigmentosa
    • Rubinstein-Taybi Syndrome 
    • Mucopolysaccharidosis, Type Vii
    • Mucopolysaccharidosis, Type IVa
      £350.00Price

      Dr. Shashank Pillai

      Longevity Specialist

      GMC registered

      Medical director & founder

      GeneGPS UK

      "TOGETHER WE will unlock your potential for optimized health and longevity."

      * Please be aware that GENEGPS genetic tests are not to be used for individuals less that the age of 18, nor if there is a disability not allowing for consent. If it is to be used for the above get in touch with us for specific consent forms. The GeneGPS packages are not appropriate for use in clinical or diagnostic settings. It is important to know that genetics deal with your code but another important factor is epigenetics which acts as a switch that turns your code on and off. Your epigenetics are governed by various modifiable factors such as environment, diet, exposures, etc. We cannot identify spontaneous changes to your genetic code    (mutations) that may or may not be linked with epigenetic/genetic factors. As a result even though a negative test can never guarantee no risk at all from serious medical conditions including cancers, neuro-degenerative conditions, etc, It still offers a risk assessment based on our advanced algorithms and current research applied to your genetic code. Nevertheless, in the event that your physician deems a mutation, DNA predisposition, allergy predisposition, medication alteration, or additional interpretations of the test results to be pertinent, standard procedure is to correlate these clinically and conduct additional investigations as needed. The information in our reports is intended to help the individual better understand their genetic makeup. We do not offer medical advice based on the results of these DNA tests.
      bottom of page